Trastuzumabe no câncer de mama metastático: uma revisão sistemática da razão custo-efetividade

Trastuzumabe no câncer de mama metastático: uma revisão sistemática da razão custo-efetividade

Show other versions (1)

Submitted by Biblioteca da Faculdade de Farmácia (bff@ndc.uff.br) on 2017-03-28T17:15:31Z No. of bitstreams: 1 Andrade, Thays Santos de [Dissertação, 2014].pdf: 467886 bytes, checksum: 9f9c6acd0d2516bb655fb10868b2db29 (MD5) === Made available in DSpace on 2017-03-28T17:15:31Z (GMT). No. of bitstr...

Full description

Bibliographic Details
Main Author:	Andrade, Thays Santos de
Other Authors:	Castilho, Selma Rodrigues de
Language:	Portuguese
Published:	Niterói 2017
Subjects:	Câncer de mama Revisão sistemática Trastuzumabe Trastuzumab Breast cancer Systematic review
Online Access:	https://app.uff.br/riuff/handle/1/3167

Similar Items

Trastuzumabe no câncer de mama metastático: uma revisão sistemática da razão custo-efetividade
by: Andrade, Thays Santos de
Published: (2017)

Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
by: Zhou Qiong, et al.
Published: (2020-07-01)

Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology∗
by: Richard M. Steingart, MD, et al.
Published: (2019-09-01)

Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population
by: Fan Yang, et al.
Published: (2020-03-01)

Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review
by: Ricardo Costa, et al.
Published: (2017-06-01)

Repercussões do câncer de mama na imagem corporal da mulher: uma revisão sistemática Breast cancer repercussion in female body image: a systematic review
by: Tatiana Rodrigues de Almeida, et al.
Published: (2012-01-01)

Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity
by: Darryl P. Leong, MBBS, MPH, MBiostat, PhD, et al.
Published: (2019-09-01)

Assessment of Carvedilol Therapy in Prevention of Heart Failure in HER2 Positive Breast Cancer Patients Receiving Trastuzumab
by: Alborz Sherafati, et al.
Published: (2019-05-01)

Short-course adjuvant trastuzumab will increase cure rates in patients with human epidermal growth factor receptor 2-positive breast cancer
by: Raymond Pierre Abratt
Published: (2017-08-01)

Lipossomas e imunolipossomas contendo fármacos antitumorais: desenvolvimento, caracterização e avaliação da eficácia contra o câncer de mama
by: Josimar de Oliveira Eloy
Published: (2016)

Lipossomas e imunolipossomas contendo fármacos antitumorais: desenvolvimento, caracterização e avaliação da eficácia contra o câncer de mama
by: Eloy, Josimar de Oliveira
Published: (2016)

Trastuzumab-Induced Myocardiotoxicity Mimicking Acute Coronary Syndrome
by: K.B. Ribeiro, et al.
Published: (2012-03-01)

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
by: Laura Díaz-Gil, et al.
Published: (2021-10-01)

Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer
by: Marinko Tanja, et al.
Published: (2018-02-01)

Effectiveness of adjuvant trastuzumab in daily clinical practice
by: Matos Erika, et al.
Published: (2014-12-01)

Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis
by: Lin-Yu Xia, et al.
Published: (2021-04-01)

Uso de trastuzumabe para o tratamento de mulheres com câncer de mama HER2 positivo: um estudo farmacoepidemiológico
by: Lorena Rocha Ayres
Published: (2015)

Uso de trastuzumabe para o tratamento de mulheres com câncer de mama HER2 positivo: um estudo farmacoepidemiológico
by: Ayres, Lorena Rocha
Published: (2015)

Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?
by: L G Zhukova, et al.
Published: (2018-06-01)

Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
by: Jagosky M, et al.
Published: (2021-06-01)

Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center
by: Michela Piezzo, et al.
Published: (2021-05-01)

Cardiac Safety of Trastuzumab on 185 Patients with HER2 Positive Breast Cancer
by: MENG Wenjing, et al.
Published: (2018-02-01)

Adjuvant trastuzumab duration trials in HER2 positive breast cancer – what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results
by: Louise Hiller, et al.
Published: (2018-04-01)

Sexualidade e câncer de mama: uma revisão sistemática da literatura
by: Daniela Barsotti Santos, et al.
Published: (2014-12-01)

A Case of Long Term Survival in Woman with Metastatic Breast Cancer Treated with Trastuzumab
by: Deyan N. Davidov
Published: (2012-02-01)

EXPERIENCE WITH SUBCUTANEOUS TRASTUZUMAB USED IN RUSSIAN FEDERATION
by: E. V. Lubennikova, et al.
Published: (2017-11-01)

Trastuzumab administration during pregnancy: un update
by: Angeliki Andrikopoulou, et al.
Published: (2021-04-01)

Interação entre especialidades: miocardiopatia dilatada e neoplasia de mama HER2 positiva Interacción entre especialidades: miocardiopatía dilatada y neoplasia de mama HER2 positiva Interaction between specialties: dilated cardiomyopathy and HER2-positive breast Cancer
by: Solange Moraes Sanches, et al.
Published: (2010-01-01)

Pertuzumab and trastuzumab: the rationale way to synergy
by: SANDRINE RICHARD, et al.
Published: (2016-01-01)

Paclitaxel and trastuzumab treatment affects insulin growth factor I expression in breast cancer cell lines
by: Yu-Xian Qian, et al.
Published: (2015-09-01)

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report
by: Patricia Miranda Romero, et al.
Published: (2015-02-01)

Actualización del tratamiento adyuvante en cáncer de mama
by: Miguel Martín, et al.
Published: (2007-12-01)

The Effects of Pertuzumab and Its Combination with Trastuzumab on HER2 Homodimerization and Phosphorylation
by: Babak Nami, et al.
Published: (2019-03-01)

Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer
by: Wesam Abdel-Razaq, et al.
Published: (2019-01-01)

Neoadjuvant combination therapy with trastuzumab in a breast cancer patient with synchronous rectal carcinoma: a case report and biomarker study
by: Vitásková Denisa, et al.
Published: (2017-12-01)

A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
by: Naohiko Nakamura, et al.
Published: (2019-04-01)

Développement d'un immunoliposome de docétaxel-trastuzumab dans le cancer du sein
by: Rodallec, Anne
Published: (2018)

Roles of adipocytes in the resistance of breast cancer to trastuzumab-mediated antibody-dependent cellular cytotoxicity (ADCC)
by: Duong, Minh Ngoc
Published: (2014)

Antagonism Between Trastuzumab and Oncolytic VSV is Overcome by Conjugation to a Microtubule Destabilizer
by: Garcia, Vanessa
Published: (2015)

A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients
by: Erika Matos, et al.
Published: (2016-01-01)